PALO ALTO, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today ...
Inventory is sitting on shelves 68.9 days, a decade high, while $1.7 trillion sits trapped in working capital. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results